Top Markets
Coin of the day
Enzo Biochem, Inc. Enzo Biochem, Inc.

Enzo Biochem, Inc.

ENZ
Rang in Aktien #28164
Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics,... Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics, clinical laboratory services, and life sciences. The company's core activities involve the entire process of researching, developing, manufacturing, and commercializing diagnostic and scientific investigation products, drawing upon advancements in genetic engineering, biotechnology, and molecular biology. Its operations are organized into three primary segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products division is responsible for creating, producing, and distributing vital tools and reagents tailored for customers in clinical research, pharmaceutical development, and broader bioscience research. Its extensive product catalog features items such as proteins, antibodies, peptides, small molecules, labeling agents, dyes, and various kits. These offerings provide life science researchers with the means for target identification and validation, content analysis, gene expression studies, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also supplies specialized solutions to scientific experts investigating critical health areas, including cancer, cardiovascular ailments, neurological disorders, metabolic conditions (like diabetes and obesity), endocrine imbalances, infectious and autoimmune diseases, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment delivers a comprehensive spectrum of molecular and other clinical laboratory tests and procedures. These are utilized by physicians in routine patient care to help confirm or establish diagnoses, monitor the effectiveness of treatments or medications, and identify previously undiagnosed medical conditions. This division operates a central, full-service clinical laboratory in Farmingdale, New York, complemented by a network of 30 patient service centers across New York and New Jersey. Additionally, it runs dedicated "STAT" or rapid-response laboratories in New York City and Connecticut, alongside a full-service phlebotomy facility and an internal logistics department. The Therapeutics segment is dedicated to pioneering novel treatment approaches within the fields of gastrointestinal, infectious, ophthalmic, and metabolic diseases. Enzo Biochem distributes its array of products and services through its dedicated internal sales team and an extensive network of distributors, reaching both domestic and international markets. The company was established in 1976 and has its corporate headquarters situated in New York, New York.
Aktienkurs
$0.5495
Zuletzt synchronisiert: 2025-05-15
Marktkapitalisierung
$28.14M
Veränderung (1 Tag)
4.70%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Enzo Biochem, Inc. (ENZ)

Kategorie

Operative Marge für Enzo Biochem, Inc. (ENZ)
Operative Marge zum August 2026 TTM: -30.77%
Laut den neuesten Finanzberichten und dem Aktienkurs von Enzo Biochem, Inc. beträgt die aktuelle operative Marge (TTM) -30.77%. Am Ende des Jahres 2023 lag die operative Marge bei -79.64%.
Historie der operativen Marge von Enzo Biochem, Inc. von 2000 bis 2026
Operative Marge zum Jahresende
Jahr Operative Marge ändert
2026 (TTM) -30.77% 0.00%
2024 -30.77% -61.36%
2023 -79.64% 450.00%
2022 -14.48% -272.59%
2021 8.39% -126.99%
2020 -31.09% -132.30%
2019 96.26% -928.40%
2018 -11.62% 309.15%
2017 -2.84% -106.21%
2016 45.73% -3,787.90%
2015 -1.24% -88.31%
2014 -10.61% -47.60%
2013 -20.25% -48.43%
2012 -39.27% 209.94%
2011 -12.67% -44.23%
2010 -22.72% -15.41%
2009 -26.86% 41.29%
2008 -19.01% -52.03%
2007 -39.63% -21.68%
2006 -50.60% 113.14%
2005 -23.74% -19.17%
2004 -29.37% -454.71%
2003 8.28% -50.24%
2002 16.64% 5.32%
2001 15.80% 55.51%
2000 10.16% 0.00%
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Operative Marge Differenz der operativen Marge Land
17.69% -100.57%
US
20.42% -100.66%
US
0.00% -
CN
-10.70% -99.65%
US
32.03% -101.04%
US
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.